MARKET

PLX

PLX

Protalix Biother
AMEX
2.148
-0.092
-4.11%
After Hours: 2.170 +0.022 +1.02% 16:05 03/13 EDT
OPEN
2.240
PREV CLOSE
2.240
HIGH
2.270
LOW
2.131
VOLUME
594.16K
TURNOVER
--
52 WEEK HIGH
2.760
52 WEEK LOW
0.8214
MARKET CAP
158.16M
P/E (TTM)
-15.7478
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PLX last week (0303-0307)?
Weekly Report · 3d ago
Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025
PR Newswire · 3d ago
Weekly Report: what happened at PLX last week (0224-0228)?
Weekly Report · 03/03 11:28
Weekly Report: what happened at PLX last week (0217-0221)?
Weekly Report · 02/24 11:28
Weekly Report: what happened at PLX last week (0210-0214)?
Weekly Report · 02/17 11:25
Weekly Report: what happened at PLX last week (0203-0207)?
Weekly Report · 02/10 11:19
Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference
PR Newswire · 02/04 11:50
Protalix BioTherapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 02/03 12:01
More
About PLX
More
Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of severe gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its product, Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase)- a chemically modified enzyme under development for the potential treatment of severe gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate.
Recently
Symbol
Price
%Change

Webull offers Protalix Biotherapeutics Inc stock information, including AMEX: PLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLX stock methods without spending real money on the virtual paper trading platform.